Tryptamine Therapeutics Ltd has named former Johnson & Johnson executive Herwig Janssen as its new non-executive chairman, marking a significant board refresh as the company prepares to enter a pivotal phase of clinical development for its lead drug candidate, TRP-8803.
The appointment, effective May 12, brings decades of global healthcare leadership to the helm of the clinical-stage biotech. Janssen brings more than 40 years of pharmaceutical sector experience, including 27 years as a vice president in J&J’s pharmaceutical arm.
American Bitcoin, a Bitcoin mining company launched earlier this year by Hut 8 Mining Corp (TSX:HUT) and backed by Donald Trump’s sons Eric Trump and Donald Trump Jr, will go public via a stock-for-stock merger with Gryphon Digital Mining.
Shares of Gryphon added 170% in the early afternoon on Monday.
Zynex Inc (NASDAQ:ZYXI) announced it has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its NiCO Noninvasive CO-Oximeter device.
The NiCO device utilizes laser pulse oximetry technology, which Zynex said can address long-standing limitations of traditional LED-based pulse oximeters, including inaccuracy in patients with darker skin tones and difficulty detecting certain hemoglobin variants.
TNR Gold Corp (TSX-V:TNR, OTC:TRRXF) said Monday that McEwen Mining has made further progress on the development of the Los Azules copper project in Argentina, where TNR holds a 0.4% net smelter returns royalty.
In its quarterly earnings update, McEwen Mining reported that its subsidiary, McEwen Copper, invested $21.3 million in the first quarter of 2025 to advance a feasibility study for the Los Azules project, one of the world’s largest undeveloped copper deposits.
BioHarvest Sciences Inc. (NASDAQ:BHST) announced the successful transition of its contract development and manufacturing (CDMO) partnership with a Nasdaq-listed pharmaceutical company from Stage 1 to Stage 2, further validating its Botanical Synthesis technology for pharmaceutical applications.
The contract, which began in early 2024, aims to develop a compound used in an approved drug product.
First Phosphate Corp. (CSE:PHOS, OTCQB:FRSPF) said over the weekend it will raise a minimum of C$1 million through a non-brokered private placement to support exploration work at its phosphate projects in Québec.
The financing will be offered at C$0.35 per security and will consist of a mix of flow-through shares and hard dollar units.
Arizona Gold & Silver Inc (TSX-V:AZS, OTCQB:AZASF) announced that it has launched Phase 2 of its metallurgical testing program at the Philadelphia gold-silver project in northwestern Arizona.
The company said that this second testing phase follows encouraging results from Phase 1, where column leach tests demonstrated gold recoveries ranging from 61% to 73% over a 177-day cycle.
Shares in Tekcapital PLC (LSE:TEK) rose 7% on Monday after its portfolio company Guident took a key step towards going public, submitting a draft registration statement to US regulators for a proposed initial public offering.
The Florida-based firm, which develops remote monitoring and support technologies for autonomous vehicles, filed the confidential paperwork with the US Securities and Exchange Commission. Details, including the number of shares on offer and the pricing range, have not yet been disclosed.
For investors searching for undervalued names in the gold space, broker Cavendish believes Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) stands out as a compelling opportunity.
The Zimbabwe-based gold producer is trading well below its estimated fair value, despite strong free cash flow, consistent dividends and a positive outlook on production.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) delivered what chief executive Mark Learmonth described as an 'exceptional' first quarter, with higher production and surging gold prices lifting profits and cash flow.
The Zimbabwe-focused gold producer reported revenue of $56.2 million for the three months to 31 March, a 46% jump on the same period last year.
Iofina PLC (AIM:IOF, OTC:IOFNF) has posted record annual revenue for the seventh year running, with strong early sales in 2025 pointing to continued demand for crystalline iodine.
The AIM-listed company, which processes oilfield brine to produce its end product, reported full-year revenue of $54.5 million for 2024, a 9% rise on the previous year.
Elixir Energy Ltd has unveiled a refreshed three-phase strategy which aims to unlock the value of its large-scale acreage in Queensland’s Taroom Trough, following a comprehensive review by its new CEO Stuart Nicholls.
The company plans to leverage a dominant position in a rapidly maturing basin, proximity to infrastructure and exposure to rising East Coast gas prices.
Andromeda Metals Ltd has raised $5 million in an oversubscribed placement, supporting its bid to fast-track early works on its flagship Great White Project and accelerate its high-purity alumina (HPA) initiative.
The placement, priced at $0.013 per share, represents a 23.5% discount to Andromeda’s previous closing price of $0.017 on May 7. A total of 384.6 million new fully paid ordinary shares will be issued to the institutional and sophisticated investors, with settlement expected on May 19 and shares allotted on May 20.
Resolution Minerals Ltd has positioned itself for near-term catalysts with early-stage work progressing at its recently acquired projects in New South Wales. The Spur South Gold-Copper Project is emerging as a compelling porphyry-skarn target, while the Drake East Gold-Antimony Project adds high-grade polymetallic upside to the company’s growing portfolio.
The delineation of a discrete 3.25 kilometre-long magnetic anomaly at Spur South—coincident with faulted Ordovician volcanic rocks and structurally favourable settings—places the project within the same mineral system corridor that hosts Newmont’s >50 million ounce Cadia gold-copper complex. For investors, this provides early-stage exposure to one of Australia’s most prolific copper-gold belts with drilling potential on the horizon.